Does Wegovy Affect Oestrogen Levels?

Why the question isn't as simple as yes or no

When people ask whether Wegovy affects oestrogen, they are usually trying to answer one of three real questions: will it disrupt my periods, will it interfere with my HRT, or could it affect my fertility? The honest starting point is that semaglutide itself does not block, mimic or directly alter oestrogen production. It works on GLP-1 receptors in the gut, pancreas and brain to reduce appetite and slow gastric emptying, the full pharmacology of semaglutide is distinct from anything in the sex-hormone pathway.

The indirect story is more nuanced. Adipose tissue (body fat) is itself a site of oestrogen production through a process called aromatisation, in which androgens are converted to oestrogens. People with higher levels of body fat can have elevated circulating oestrogen as a result. As Wegovy produces meaningful weight reduction (clinical trials reported an average reduction of around 15% of body weight at the 2.4 mg maintenance dose) that source of oestrogen diminishes. For some women, particularly those who are post-menopausal or who have polycystic ovary syndrome, this shift can be clinically relevant. It is worth reading how Wegovy affects various body markers alongside this page for the broader picture.

The practical upshot: any hormonal changes you notice on Wegovy are more likely a downstream effect of losing weight than a direct pharmacological action of semaglutide. That does not make them less real, but it does point toward the right conversation, one about your weight, your hormone profile, and your individual history, not simply about the medicine itself.

Periods, cycle changes and what clinical evidence actually says

Some women on semaglutide report changes to their menstrual cycle, particularly in the early months of treatment. Heavier periods, lighter periods, or temporary irregularity are all reported anecdotally. The clinical development programme for Wegovy was not specifically powered to measure menstrual-cycle outcomes, so robust trial data on this point is limited.

What reproductive endocrinology does tell us is that rapid or significant changes in body weight can shift the balance of sex hormones, including oestrogen and luteinising hormone (LH), which in turn can alter cycle length and regularity. This is a well-documented pattern in women recovering from obesity or losing weight through other means, and it is reasonable to expect a similar pattern with Wegovy-supported weight loss.

For women with PCOS specifically, weight loss often improves hormonal balance over time, reduced androgen levels, more regular ovulation, and a shift in the oestrogen-to-androgen ratio. That can be a benefit, but it also underscores the fertility point: ovulation may resume or become more predictable in women who had irregular cycles due to PCOS and excess weight. If you are not planning a pregnancy, that is an important reason to review your contraception before you start treatment. Our guidance on Wegovy and HRT interactions covers the oral contraceptive absorption question in more detail.

As NHS England's guidance on weight-management injections makes clear, contraception choices and hormone management should be discussed with the prescribing clinician before and during treatment, not treated as a separate matter.

HRT, oral contraceptives and the absorption point worth knowing

There is one direct, practical interaction involving hormonal medicines that does apply to Wegovy treatment, though it relates to drug absorption rather than to oestrogen levels as such. Because GLP-1 medicines slow gastric emptying, there is a theoretical concern that oral medicines (including oral contraceptive pills) may be absorbed more variably, particularly in the first weeks of treatment or after a dose increase.

NHS England's guidance is specific on this: for women taking oral contraceptives alongside GLP-1 weight-loss medicines, adding a non-oral method (such as condoms) as a precaution during the early period of treatment is worth discussing with your prescriber. The guidance also notes that women on oral HRT should consider whether a transdermal form (a patch or gel) might be more appropriate during treatment, since absorption is not affected by gastric-emptying rate in the same way. The dedicated page on Wegovy and HRT goes through this in full. You may also find it useful to check how Wegovy affects blood-sugar regulation if you are managing diabetes or prediabetes alongside any hormonal condition.

None of this means Wegovy cannot be used alongside HRT or oral contraceptives. It means the conversation with your prescriber should cover all of your current medicines, not just the ones that feel obviously relevant. A good prescriber will ask. If yours does not, raise it yourself.

When to raise this with a clinician

If you are already on Wegovy and noticing changes (irregular periods, heavier bleeding, shifts in mood that feel hormonal, or unexpected pregnancy risk) those are conversations for your prescriber or GP, not something to manage alone. The same is true if you are on HRT and wondering whether your current formulation still makes sense at your new or changing weight.

For anyone starting treatment, the assessment stage is the right moment to mention your menstrual history, any hormonal conditions (PCOS, endometriosis, perimenopause), your current contraception, and any HRT. The different dose stages of Wegovy each represent a period of adjustment, and a prescriber who knows your full picture can support you through them more confidently. Broad guidance on the range of weight-loss treatments available may also help you frame the wider decision.

At some point during the day (perhaps while you are making your morning coffee, well before the school-run rush) it takes about ten minutes to complete the consultation form. That initial conversation, reviewed the same day by a real clinician at our pharmacy, is where the specific questions about your hormones, your medicines and your history can be properly assessed. If you have questions in the meantime, the team is reachable through our contact page.

When you are ready, speak to our prescribers through a free consultation and have the full picture reviewed by a GPhC-registered Independent Prescriber before starting treatment.